Anthera Pharmaceuticals Inc. (Nasdaq: ANTH) regained compliance with Nasdaq listing requirements. The stock price gained 57 cents to $3.82.
Anthera Pharmaceuticals regains compliance
February 11, 2015 at 11:42 AM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.